找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Real-World Evidence in Medical Product Development; Weili He,Yixin Fang,Hongwei Wang Book 2023 The Editor(s) (if applicable) and The Autho

[復制鏈接]
查看: 41258|回復: 59
樓主
發(fā)表于 2025-3-21 18:21:07 | 只看該作者 |倒序瀏覽 |閱讀模式
書目名稱Real-World Evidence in Medical Product Development
編輯Weili He,Yixin Fang,Hongwei Wang
視頻videohttp://file.papertrans.cn/823/822311/822311.mp4
概述A first-of-its-kind, structured end-to-end, comprehensive perspectives from different stakeholders, with real examples.Includes special chapters on estimand, causal inference roadmap, fit-for-purpose
圖書封面Titlebook: Real-World Evidence in Medical Product Development;  Weili He,Yixin Fang,Hongwei Wang Book 2023 The Editor(s) (if applicable) and The Autho
描述.This book provides state-of-art statistical methodologies, practical considerations from regulators and sponsors, logistics, and real use cases for practitioners for the uptake of RWE/D. Randomized clinical trials have been the gold standard for the evaluation of efficacy and safety of medical products. However, the cost, duration, practicality, and limited generalizability have incentivized many to look for alternative ways to optimize drug development. This book provides a comprehensive list of topics together to include all aspects with the uptake of RWE/D, including, but not limited to, applications in regulatory and non-regulatory settings, causal inference methodologies, organization and infrastructure considerations, logistic challenges, and practical use cases..
出版日期Book 2023
關鍵詞real-world evidence; real-world data; design bias; confounding control; regulatory science; machine learn
版次1
doihttps://doi.org/10.1007/978-3-031-26328-6
isbn_softcover978-3-031-26330-9
isbn_ebook978-3-031-26328-6
copyrightThe Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Switzerl
The information of publication is updating

書目名稱Real-World Evidence in Medical Product Development影響因子(影響力)




書目名稱Real-World Evidence in Medical Product Development影響因子(影響力)學科排名




書目名稱Real-World Evidence in Medical Product Development網(wǎng)絡公開度




書目名稱Real-World Evidence in Medical Product Development網(wǎng)絡公開度學科排名




書目名稱Real-World Evidence in Medical Product Development被引頻次




書目名稱Real-World Evidence in Medical Product Development被引頻次學科排名




書目名稱Real-World Evidence in Medical Product Development年度引用




書目名稱Real-World Evidence in Medical Product Development年度引用學科排名




書目名稱Real-World Evidence in Medical Product Development讀者反饋




書目名稱Real-World Evidence in Medical Product Development讀者反饋學科排名




單選投票, 共有 1 人參與投票
 

1票 100.00%

Perfect with Aesthetics

 

0票 0.00%

Better Implies Difficulty

 

0票 0.00%

Good and Satisfactory

 

0票 0.00%

Adverse Performance

 

0票 0.00%

Disdainful Garbage

您所在的用戶組沒有投票權限
沙發(fā)
發(fā)表于 2025-3-21 23:37:41 | 只看該作者
板凳
發(fā)表于 2025-3-22 04:15:34 | 只看該作者
https://doi.org/10.1007/978-3-031-26328-6real-world evidence; real-world data; design bias; confounding control; regulatory science; machine learn
地板
發(fā)表于 2025-3-22 06:38:32 | 只看該作者
978-3-031-26330-9The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Switzerl
5#
發(fā)表于 2025-3-22 10:48:29 | 只看該作者
6#
發(fā)表于 2025-3-22 16:36:17 | 只看該作者
7#
發(fā)表于 2025-3-22 19:14:17 | 只看該作者
Overview of the Current Real-World Evidence Regulatory Landscaperld. We will first outline the key concepts underpinning evaluation of real-world evidence and discuss similarity and differences in those concepts in guidance documents from different countries. Then, we illustrate the regulatory practice of using real-world data throughout the product development
8#
發(fā)表于 2025-3-22 23:28:57 | 只看該作者
Key Considerations in Forming Research Questions and Conducting Research in Real-World Settingred through real-world studies and the analysis of real-world data. The derived real-world evidence may be used to help support approval of a new indication for a medical product that has already been approved or to help support postapproval study requirements. We also discuss how to revise the rese
9#
發(fā)表于 2025-3-23 02:13:29 | 只看該作者
10#
發(fā)表于 2025-3-23 08:40:48 | 只看該作者
Key Variables Ascertainment and Validation in RW Settingam. ., 2018). Key variables are those that define a key patient characteristic necessary to identify the study population of interest, the treatment/exposure, the outcome, or a key confounder whose effect must be adjusted for. With Real-World Data (RWD), often (1) exposure, outcomes, and key confoun
 關于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學 Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結 SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學 Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-6 21:57
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權所有 All rights reserved
快速回復 返回頂部 返回列表
临猗县| 临城县| 班戈县| 营山县| 汝城县| 张家川| 湾仔区| 泌阳县| 东至县| 隆回县| 自治县| 嵊泗县| 栖霞市| 长子县| 邵武市| 亳州市| 闵行区| 工布江达县| 黎川县| 中江县| 三门县| 丰城市| 黄大仙区| 唐海县| 普安县| 伊吾县| 忻州市| 明光市| 大田县| 漳州市| 合山市| 阿拉善左旗| 若尔盖县| 忻州市| 乌海市| 福州市| 奉新县| 南澳县| 宁陵县| 恩平市| 马公市|